Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2014/11/005190
CTRI/2014/11/005190
Recruiting
Phase 3

Comparison of continuous infusion versus intermittent bolus doses of fentanyl for analgesia in neonatesâ?? An open label randomized controlled trial - FANCI trial

Institutional Review Board0 sites98 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Institutional Review Board
Enrollment
98
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Newborn babies who are likely to require mechanical ventilation for 48 hours (minimum 24 hours)

Exclusion Criteria

  • •1\.Major congenital anomalies/ chromosomal disorders 2\.Hypoxic Ischemic encephalopathy (HIE) stage 2 or 3 3\.Postoperative babies
  • •4\.Refusal of consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Treatment of Organophosphate poisoning with Pralidoxime
IRCT20180613040087N1Shiraz University of Medical Sciences80
Completed
Phase 2
Comparison of two different methods of drug administration in Adductor Canal Block after Knee arthroplasty.
CTRI/2019/01/017279AIIMS Rishikesh80
Not yet recruiting
Not Applicable
We compare continuous infusion and intermittent bolus infusion post operative patient-controlled analgesia with erector spinae block catheterHealth Condition 1: C509- Malignant neoplasm of breast of unspecified site
CTRI/2021/05/033759AIIMS Patna
Completed
Not Applicable
Comparison of continuous medication versus intermittent medication through regional anaesthetic technique in breast cancer patients undergoing surgeryHealth Condition 1: C508- Malignant neoplasm of overlappingsites of breast
CTRI/2019/08/020751AIIMS50
Active, not recruiting
Phase 1
Continuous infusion versus intermittent administration of meropenem in critically ill patients. A multicenter randomized double blind trial.We are planning a large multicentre randomized controlled study to confirm the beneficial effect of continuous infusion of meropenem against bolus administration as indicated by a composite outcome of reducing death, and emergence of extensive or pan drug resistant pathogens in a population of severely ill patients.MedDRA version: 20.0Level: LLTClassification code 10062357Term: SIRSSystem Organ Class: 100000004867Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2016-002052-24-ITOSPEDALE SAN RAFFAELE600